ATA833878A - Verfahren zur herstellung von 5,6,9,17,19,21- -hexahydro-23-methoxy-2,4,12,16,18,20,22- heptamethyl-8-(n-(4-methyl-1-piperazinyl)- formimidoyl)-2,7-(epoxypentadeca(1,11,13)- trienimino)-naphtho(2,1-b)furan-1,11(2h)-dion- 21-acetat - Google Patents

Verfahren zur herstellung von 5,6,9,17,19,21- -hexahydro-23-methoxy-2,4,12,16,18,20,22- heptamethyl-8-(n-(4-methyl-1-piperazinyl)- formimidoyl)-2,7-(epoxypentadeca(1,11,13)- trienimino)-naphtho(2,1-b)furan-1,11(2h)-dion- 21-acetat

Info

Publication number
ATA833878A
ATA833878A AT833878A AT833878A ATA833878A AT A833878 A ATA833878 A AT A833878A AT 833878 A AT833878 A AT 833878A AT 833878 A AT833878 A AT 833878A AT A833878 A ATA833878 A AT A833878A
Authority
AT
Austria
Prior art keywords
trienimino
epoxypentadeca
formimidoyl
heptamethyl
dion
Prior art date
Application number
AT833878A
Other languages
English (en)
Other versions
AT362062B (de
Inventor
Tiberio Bruzzese
Original Assignee
Holco Investment Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Holco Investment Inc filed Critical Holco Investment Inc
Publication of ATA833878A publication Critical patent/ATA833878A/de
Application granted granted Critical
Publication of AT362062B publication Critical patent/AT362062B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT833878A 1977-11-25 1978-11-22 Verfahren zur herstellung von 5,6,9,17,19,21- -hexahydro-23-methoxy-2,4,12,16,18,20,22- heptamethyl-8-(n-(4-methyl-1-piperazinyl)- formimidoyl) -2,7-(epoxypentadeca(1,11,13)- trienimino)-naphtho(2,1-b)furan-1,11(2h)-dion- 21-acetat AT362062B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB49148/77A GB1594134A (en) 1977-11-25 1977-11-25 Rifamycins

Publications (2)

Publication Number Publication Date
ATA833878A true ATA833878A (de) 1980-09-15
AT362062B AT362062B (de) 1981-04-27

Family

ID=10451344

Family Applications (1)

Application Number Title Priority Date Filing Date
AT833878A AT362062B (de) 1977-11-25 1978-11-22 Verfahren zur herstellung von 5,6,9,17,19,21- -hexahydro-23-methoxy-2,4,12,16,18,20,22- heptamethyl-8-(n-(4-methyl-1-piperazinyl)- formimidoyl) -2,7-(epoxypentadeca(1,11,13)- trienimino)-naphtho(2,1-b)furan-1,11(2h)-dion- 21-acetat

Country Status (15)

Country Link
US (1) US4174320A (de)
JP (1) JPS5479299A (de)
AR (1) AR219549A1 (de)
AT (1) AT362062B (de)
AU (1) AU524481B2 (de)
BE (1) BE872233A (de)
CA (1) CA1095035A (de)
DE (1) DE2846321A1 (de)
FR (2) FR2422665A1 (de)
GB (1) GB1594134A (de)
GR (1) GR72969B (de)
IN (2) IN149404B (de)
IT (1) IT1100590B (de)
PH (1) PH15017A (de)
YU (2) YU40836B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308166D0 (en) * 1983-03-24 1983-05-05 Erba Farmitalia Preparation of azinomethyl-rifamycins
GB8318072D0 (en) * 1983-07-04 1983-08-03 Lepetit Spa Water-soluble rifampicin derivatives
GB8531887D0 (en) * 1985-12-30 1986-02-05 Lepetit Spa Rifamycin sv derivatives
CN100383143C (zh) * 2004-04-29 2008-04-23 薛荔 一锅烩合成利福平的方法
WO2009137380A1 (en) * 2008-05-05 2009-11-12 Janssen Pharmaceutica Nv 3-hydrazone piperazinyl rifamycin derivatives useful as antimicrobial agents
CN102660598B (zh) * 2012-05-31 2014-01-22 河南省南街村(集团)有限公司 一种提高利福霉素sv发酵产量的方法
CN103772413B (zh) * 2014-02-07 2016-01-20 天津大学 一种利福平ⅱ晶型的制备方法
CN111848639A (zh) * 2020-07-09 2020-10-30 华东理工大学 一种合成利福平的工艺方法
KR102688151B1 (ko) 2021-12-28 2024-07-24 주식회사 종근당바이오 Mnp가 저감된 리팜피신의 신규 제조방법
WO2023218419A1 (en) 2022-05-13 2023-11-16 Olon S.P.A. Purification process of rifampicin from nitrosamines
WO2024009248A1 (en) 2022-07-08 2024-01-11 Olon S.P.A. Method and assembly for the control of the formation of a nitrosamine impurity in a solid active pharmaceutical ingredient

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR208F (de) * 1964-07-31
US3542762A (en) * 1967-06-07 1970-11-24 Lepetit Spa Process for rifamycins
IT1046627B (it) * 1970-06-01 1980-07-31 Lepetit Spa Composizioni antivirali contenenti derivati della rifaumicina sv
AR207762A1 (es) * 1973-07-25 1976-10-29 Archifar Ind Chim Trentino Procedimiento para la preparacion de 3-((4-metil-1-piperazin-1-il)-imino)-metil-rifamicina sv o rifampicina
GB1478563A (en) * 1975-03-05 1977-07-06 Lepetit Spa Rifamycin derivatives

Also Published As

Publication number Publication date
CA1095035A (en) 1981-02-03
YU211782A (en) 1983-01-21
DE2846321C2 (de) 1991-04-25
IN149404B (de) 1981-11-28
FR2422665B1 (de) 1983-12-16
AU524481B2 (en) 1982-09-16
IN151954B (de) 1983-09-10
IT7830194A0 (it) 1978-11-24
IT1100590B (it) 1985-09-28
BE872233A (fr) 1979-03-16
AU4016878A (en) 1980-04-03
JPS5479299A (en) 1979-06-25
DE2846321A1 (de) 1979-05-31
GR72969B (de) 1984-01-20
US4174320A (en) 1979-11-13
YU40836B (en) 1986-06-30
FR2422665A1 (fr) 1979-11-09
GB1594134A (en) 1981-07-30
AR219549A1 (es) 1980-08-29
PH15017A (en) 1982-05-10
JPS5740155B2 (de) 1982-08-25
AT362062B (de) 1981-04-27
FR2438048B1 (de) 1982-12-03
FR2438048A1 (fr) 1980-04-30
YU273078A (en) 1983-01-21

Similar Documents

Publication Publication Date Title
AT351532B (de) Verfahren zur herstellung von 6a,10a-trans-1- hydroxy-3-substituierten-6,6-dimethyl-6,6a,7,8, 10,10a-hexahydro-9h-dibenzo(b,d)-pyran-9-onen
ATA736977A (de) Verfahren zur herstellung von 1,4:3,6- dianhydro-d-glucit-2-nitrat
AT362062B (de) Verfahren zur herstellung von 5,6,9,17,19,21- -hexahydro-23-methoxy-2,4,12,16,18,20,22- heptamethyl-8-(n-(4-methyl-1-piperazinyl)- formimidoyl) -2,7-(epoxypentadeca(1,11,13)- trienimino)-naphtho(2,1-b)furan-1,11(2h)-dion- 21-acetat
AT351508B (de) Verfahren zur herstellung von 2,5-dichlorphenol
DE3585109D1 (de) Verfahren zur herstellung von (+/-)-3a,6,6,9a-tetramethylperhydronaphtho(2,1-b)furan.
AT358031B (de) Verfahren zur herstellung von 1-azolyl-3,3- dimethyl-1-phenoxy-butan-2-onen
AT356126B (de) Verfahren zur herstellung von 3,4-dihydro-2- -methyl-4-oxo-2h-1,2-benzothiazin-3-carboxamid- -1,1-dioxid
AT359990B (de) Verfahren zur herstellung von 1,3-dihydroxy-2- -aminopropan
AT376970B (de) Verfahren zur herstellung von 2,3-dihydro-2,2dimethyl-7-hydroxybenzofuran
AT360507B (de) Verfahren zur herstellung von 2,4,5-trichlor- phenol
AT377586B (de) Verfahren zur herstellung von substituierten pyrrolo-(2,1-b)-chinazolinen und pyrido(2,1-b)chinazolinen
AT353268B (de) Verfahren zur herstellung von 6a,10a-cis- hexahydrodibenzopyranonen
AT356815B (de) Verfahren zur herstellung von 3',4'-dideoxy- kanamycin b
AT352276B (de) Verfahren zur herstellung von neuen 7-(alpha- (2,3-dihydro-2-oxo-1h-benzimidazol-1- ylcarbonylamino)arylacetamido)-cephalosporinen
AT358055B (de) Verfahren zur herstellung von 2-chlor-4,6-bis- -alkylamino-s-triazinen
ATA817779A (de) Verfahren zur herstellung von 7-chlor-2-methyl-3,3a-dihydro-2h,9h-isoxazol (3,2-b) (1,3)-benzoxazin-9-on
AT358057B (de) Verfahren zur herstellung von halogenalkylsub- stituierten oxiranen
ATA483477A (de) Verfahren zur herstellung von dl-6a,10a-cis-1- hydroxy-3-substituierten-6,6-dimethyl-6,6a,7,8, 10,10a-hexahydro-9h-dibenzo(b,d)pyran-9-onen
AT359476B (de) Verfahren zur herstellung von 2,3-dichlor-1-(c1 -7)-alkoxybenzol
AT360025B (de) Verfahren zur herstellung des cis-isomeren von n,n-dimethyl-9-(3-(4-methyl-1-piperazinyl) propyliden)-thioxanthen-2-sulfonamid in isolierter form
ATA483777A (de) Verfahren zur stereoselektiven herstellung optisch aktiver 6a,10a-trans-1-hydroxy-3- substituierter-6,6-dimethyl-6,6a,7,8,10,10a- hexahydro-9h-dibenzo(b,d)pyran-9-one
AT375653B (de) Verfahren zur herstellung von 2-oxodihydrobenzo(d)(1,3)-oxazinen
AT373872B (de) Verfahren zur herstellung von 2,2-dialkyl-4-methyl-5,5-dialkyl-3-formyl-3-pyr olinen
AT371805B (de) Verfahren zur herstellung von n-dialkylaminomethyl-s,s-diarylsulfoximiden
AT368120B (de) Verfahren zur herstellung von dicyclopentyl -(2,2'-bis(4-alkyl-6-tert.butylphenolen))

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee